Network Insights Methodology Get Access

Rocket

ORG Technology / Application Software Momentum 9.1ML Momentum Score (0-100). Weighted composite of 9 features: mention velocity, article breadth, relationship density, deal context, recency, market cap, enrichment completeness, mention concentration, entity type. NORMALPSI regime classification. QUIET (<0.3): baseline activity. NORMAL (0.3-0.5): typical deal flow. ELEVATED (0.5-0.7): above-average signals. HIGH (0.7-0.85): significant activity. EXTREME (>0.85): exceptional signal concentration.

Rocket.new is a web development platform competing in the low-code/no-code space. The product positions itself as an alternative to Lovable, offering expanded functionality for rapid application development.

0.00
PSI ScorePlocamium Signal Index - composite z-score from 5 orthogonal signals: news frequency, targeted sentiment, graph centrality, regulatory filings, and clinical trial activity.
9.1
MomentumML Momentum Score (0-100). Weighted composite of 9 features including mention velocity, article breadth, deal context, and relationship density. Retrained weekly.
0%
ConfidenceSignal confidence - percentage of PSI sub-signals with sufficient data (30+ observations). Higher confidence means the PSI score is based on more complete data.
2
ConnectionsDegree centrality - number of unique entities this entity co-occurs with in news signals and articles. Higher = more connected in the intelligence network.
Connected Entities
FDA Pfizer
Watch This Entity
PSI Intelligence
30-Day Trend
2026-04-22 2026-05-22 3 0 Degree Mentions
Signal Decomposition
No signal data available.
Peer Comparison
Not yet ranked. Sector-relative scoring requires at least four entities in the same BICS sector with PSI history; this entity does not yet meet the threshold or sits in a sector with insufficient peers.
Network Analysis
2 Degree Centrality
Ego Network (top connections)
FDA (weight 6.0)Pfizer (weight 2.0) FDAPfizer Rocket (degree 2) Rocket
Centrality History
2026-04-22 2026-05-22 3 0 Degree Mentions
EntityWeight StatusFirst Seen
FDA 6 NEW
Pfizer 2 NEW
Article Coverage (0)
DateLaneTitle
No Plocamium-authored coverage yet. This entity surfaces in upstream signals (news, filings, trials) but has not yet been a primary subject of a published article. Watch this entity to be alerted when one is published.

Request Access

Full PSI intelligence, network analysis, EDGAR filings, and predicted links require an access token.

Data as of 2026-05-22 ← Intelligence Network